dm+d
36642006
Articles
Using gastrointestinal antispasmodics during breastfeeding
29 January 2024
Medicine Compliance Aid Stability
Pro-BanthineKyowa Kirin Ltd
Kyowa Kirin Ltd
Pro-Banthine
Tablets s/c 15mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from light
Protect from light. Airtight container.
22 November 2022
Lactation Safety Information
As GI antispasmodic
As GI antispasmodic
Mebeverine
No published evidence of safety
Used in infants >1 month
Low levels anticipated in milk due to the drug’s properties
See summary for further information on anticholinergic affects
29 July 2020
For enuresis
For enuresis
Low levels anticipated in milk due to the drug's properties
No published evidence of safety
Monitor infant for anticholinergic effects, e.g. urinary retention, colic and constipation
29 July 2020